Skip to main content

Table 7 Distribution of reported adverse events by treatment arm

From: Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether–lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial

Adverse events

Control arm

Intervention arm

Fever, n (%)

7 (30.4)

3 (13.6)

Abdominal pain, n (%)

4 (17.4)

4 (18.2)

Headache, n (%)

3 (13.0)

4 (18.2)

Asthenia, n (%)

3 (13.0)

3 (13.6)

Dizziness, n (%)

3 (13.0)

2 (9.1)

Vomiting, n (%)

1 (2.3)

3 (13.6)

Nausea, n (%)

1 (2.3)

3 (13.6)

Rashes, n (%)

1 (2.3)

0 (0)

Diarrhoea, n (%)

0 (0)

0 (0)

Total N (%)

23 (100)

22 (100)